arBtrage CAPITALIZING MARKETS checking… Sign in Sign up

Vertex Pharmaceuticals Incorporated

VRTX Health Care Biotechnology: Pharmaceutical Preparations
$446.83
▲ +1.1% Today
as of Jun 7, 07:31 ET
Last 30 days +3.88% Apr 28 → Jun 05
$420.85 $429.50 $438.15 $446.80 $455.45 Apr 28 May 05 May 13 May 20 May 29 Jun 05
Open
$445.61
High
$453.16
Low
$443.86
Volume
$2M
Avg Vol
$1M
Mkt Cap
$113.7B
P/E (TTM)
36.60
Beta
52w High
$507.92
52w Low
$362.50
Div Yield
Shares Out
$254M

Overview

52-week range
$362
$508
58% of range
Avg surprise (last 2)
+1.6%
Avg reaction (last 2)
+0.6%
50% positive
Latest IV / EM
39%
EM ±3.6% · $448 · Jun 12

Earnings trends

EPS — actual vs estimate Actual Estimate
$-13.92$-9.39$-4.86$-0.32$4.21 Actual $3.52Actual $3.97Actual $4.21Actual $-13.92Actual $4.01Actual $3.55Est $3.69Actual $3.99Actual $4.20Actual $3.95Est $3.69 JunSepMarJunSepMar/2025JunSepMar/2026
Revenue vs Net Income Revenue Net income
$-3.6B$-2.4B$-1.2B$-46M$1.1B Jun 24Sep 24Mar 25Jun 25Sep 25Mar 26

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Mon May 4, 2026Mar/2026 $3.95 $3.69 +7.0% +11.3% +1.4% earnings
Tue Sep 30, 2025Sep 2025 $4.20 financials
Mon Jun 30, 2025Jun 2025 $3.99 financials
Mon May 5, 2025Mar/2025 $3.55 $3.69 -3.8% -0.2% earnings
Mon Sep 30, 2024Sep 2024 $4.01 financials
Sun Jun 30, 2024Jun 2024 $-13.92 financials
Sun Mar 31, 2024Mar 2024 $4.21 financials
Sat Sep 30, 2023Sep 2023 $3.97 financials
Fri Jun 30, 2023Jun 2023 $3.52 financials

Financials

Income statement (quarterly)

MetricMar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024
Revenue
Cost of revenue$393M$415M$408M$363M$393M$372M
Gross profit
Operating income$1.14B$1.19B$1.15B$630M$1.12B$-3.51B
Net income$1.03B$1.08B$1.03B$646M$1.05B$-3.59B
EPS (diluted)$4.02$4.20$3.99$2.49$4.01$-13.92

Balance sheet (quarterly)

MetricMar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024
Cash & equivalents$5.49B$5.08B$4.94B$4.97B$4.67B$4.57B$5.24B$4.58B
Inventory$1.77B$1.69B$1.63B$1.50B$1.36B$1.21B$1.08B$915M
Total current assets$11.73B$11.20B$10.57B$10.43B$10.01B$9.60B$9.80B$8.94B
Total assets$26.48B$25.64B$24.86B$24.04B$22.88B$22.53B$22.24B$20.13B
Long-term debt
Total liabilities$7.12B$6.98B$7.54B$6.86B$6.38B$6.12B$6.61B$5.36B
Total equity$19.36B$18.67B$17.32B$17.18B$16.50B$16.41B$15.63B$14.77B

Implied volatility — last 90 days

34%36%39%41%44% Jun 07 — IV 39% · EM ±3.6%

Sector peers